← Back to the feed

Robonnement AG

History from 2 Dec 2020

UID

CHE-107.301.354

Legal form

AG

Canton

SG

Founded

not in the record

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 19 Dec 2024 · legal date 12 Dec 2024

   Name changed

   K Lips AG → Robonnement AG

   SHAB HR02-1006210333 ↗

2. SHAB published 21 Jul 2025 · legal date 7 Jul 2025

   Capital increase

   Not assessed

   Paid in cash and by other means

   Nominal capital

   160’000 → 196’328

   Shares

   400 → 196’328

   New shares, % of post-step shares

   — (nominal value per share changed)

   Share classes

   176’695 × CHF 1 · 19’633 × CHF 1 Vorzugsaktien

   Aktienkapital neu: CHF 196'328.00 [bisher: CHF 160'000.00]. Liberierung Aktienkapital neu: CHF 196'328.00 [bisher: CHF 160'000.00]. Aktien neu: 176'695 Namenaktien zu CHF 1.00 und 19'633 Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 400 Namenaktien zu CHF 400.00].

   SHAB HR02-1006389964 ↗

3. SHAB published 2 Dec 2025 · legal date 20 Nov 2025

   Capital increase

   ○○○Capital increased

   Issued from conditional capital

   Nominal capital

   196’328 → 306’000

   Shares

   196’328 → 306’000

   New shares, % of post-step shares

   35.8% (109’672 new)

   Share classes

   176’695 × CHF 1 · 129’305 × CHF 1 Vorzugsaktien

   Aktienkapital neu: CHF 306'000.00 [bisher: CHF 196'328.00]. Liberierung Aktienkapital neu: CHF 306'000.00 [bisher: CHF 196'328.00]. Aktien neu: 176'695 Namenaktien zu CHF 1.00 und 129'305 Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 19'633 Namenaktien zu CHF 1.00 (Vorzugsaktien) und 176'695 Namenaktien zu CHF 1.00]. Die Gesellschaft hat mit Beschluss vom 20.11.2025 ein Kapitalband gemäss näherer Umschreibung in den Statuten eingeführt.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5
   • Shares issued out of conditional capital, as when options are exercised.−1.0

   Classifier score 0.20 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006500489 ↗

4. SHAB published 2 Dec 2025 · legal date 20 Nov 2025

   Capital band adopted

   SHAB HR02-1006500489 ↗

5. SHAB published 15 Jun 2026 · legal date 29 May 2026

   Capital increase

   ●●○Likely financing

   Paid in cash and by other means

   Nominal capital

   306’000 → 341’695

   Shares

   306’000 → 341’695

   New shares, % of post-step shares

   10.4% (35’695 new)

   Share classes

   181’695 × CHF 1 · 160’000 × CHF 1 Vorzugsaktien

   Aktienkapital neu: CHF 341'695.00 [bisher: CHF 306'000.00]. Liberierung Aktienkapital neu: CHF 341'695.00 [bisher: CHF 306'000.00]. Aktien neu: 181'695 Namenaktien zu CHF 1.00 und 160'000 Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 129'305 Namenaktien zu CHF 1.00 (Vorzugsaktien) und 176'695 Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung innerhalb Kapitalband.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.75 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006677009 ↗

Published by 21 Jun 2026

Latest available record · 8 Oct 2026